Steven M. Fruchtman
2017
In 2017, Steven M. Fruchtman earned a total compensation of $504.6K as Chief Medical Officer and Senior Vice President, Research and Development at Onconova Therapeutics, a 27% decrease compared to previous year.
Compensation breakdown
| Option Awards | $49,105 |
|---|---|
| Salary | $436,154 |
| Other | $19,315 |
| Total | $504,574 |
Fruchtman received $436.2K in salary, accounting for 86% of the total pay in 2017.
Fruchtman also received $49.1K in option awards and $19.3K in other compensation.
Rankings
In 2017, Steven M. Fruchtman's compensation ranked 11,831st out of 14,666 executives tracked by ExecPay. In other words, Fruchtman earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,831 out of 14,666 | 19th |
Division Manufacturing | 4,655 out of 5,772 | 19th |
Major group Chemicals And Allied Products | 1,697 out of 2,075 | 18th |
Industry group Drugs | 1,407 out of 1,731 | 19th |
Industry Pharmaceutical Preparations | 1,100 out of 1,333 | 18th |
Source: SEC filing on June 8, 2018.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2017.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019